A rapid, high-sensitivity SARS-CoV-2 nucleocapsid immunoassay to aid diagnosis of acute COVID-19 at the point of care | medRxiv
COVID-19 SARS-CoV-2 Antibody Test | LumiraDx
LumiraDx Instrument for Rapid Detection of SARS-CoV-2 Instrument for Rapid | Fisher Scientific
Non riconoscono tre positivi su dieci”. L'atto d'accusa contro i test rapidi - la Repubblica
LumiraDx launches C-Reactive Protein test to combat antimicrobial resistance in India, ET HealthWorld
Tutti i cataloghi e le schede tecniche LumiraDx
Workplace On-Site Testing for COVID-19 | LumiraDx (US)
IJERPH | Free Full-Text | Rapid Antigen Test LumiraDxTM vs. Real Time Polymerase Chain Reaction for the Diagnosis of SARS-CoV-2 Infection: A Retrospective Cohort Study
LumiraDx Expands its Cardiovascular Testing Portfolio with CE Marking of its NT-proBNP Test and new Exclusion Claim for its D-Dimer Test
LumiraDx five-minute SARS-CoV-2 Ag Ultra Test achieves CE Marking
LumiraDx Instrument for Rapid Detection of SARS-CoV-2 Instrument for Rapid | Fisher Scientific
LumiraDx bags CDSCO approval for COVID-19 antigen test
LumiraDx riceve l'autorizzazione per il test antigenico SARS-CoV-2 in Giappone e Brasile; l'Italia raccomanda l'espansione del test antigenico basato su microfluidica
LumiraDx SARS-CoV-2 Antigen Test supports COVID-19 prevention at Rotenburg District Hospital
Test rapidi di sangue LumiraDx - Tutti i prodotti su MedicalExpo
Sistema diagnostico point-of-care (POCT) di ultima generazione | LumiraDx (Italia)
Test point-of-care | LumiraDx (Italia)
Coronavirus: Welsh NHS to adopt 12-minute testing kit - BBC News
Balancing the accuracy and cost of antigen testing | Evaluate
LumiraDx – Point of Care Testing Innovators
LumiraDx Antigen Test Supports Established Testing Concepts with Rapid and Accurate Results in Germany